Iran launched the production of ACTEMRA for the treatment of COVID-19 patients, Mehr reported referring to the Director-General of Iran’s Food and Drug Administration (IFDA) for Drugs and Controlled Substances Affairs Heidar Mohammadi.

"In addition to Remdesivir, ACTEMRA drug, which effectiveness has been approved by US Food and Drug Administration in the relative recovery of patients suffering from coronavirus, COVID-19, will be distributed at hospitals within the next two weeks." Heidar Mohammadi told IRNA on Monday.